Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 76Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia 36Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 7Burkitt Lymphoma 7Neoplasm, Residual 6Myelodysplastic Syndromes 6Congenital Abnormalities 6Leukemia, Biphenotypic, Acute 4Recurrence 3Leukemia, Promyelocytic, Acute 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Philadelphia Chromosome 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Thrombocytopenia 1Sarcoma 1

Interventions

Daunorubicin 2Cytarabine 2prednylidene 1Vincristine 1Prednisolone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Hydrocortisone 1Etoposide 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Down Syndrome × Daunorubicin × Clear all
NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07232134 2025-11-20

AML-DS-2025

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting
100 enrolled
Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡